Federal award
ORTHO-CLINICAL DIAGNOSTICS GMBH
FA560618P0001
Contract
Obligated and Ceiling
- Obligated (net)
- $112,303.97
- Ceiling (potential value, not spending)
- $112,303.97
- Current value
- $112,303.97
- Gross positive obligations
- $114,076.67
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ORTHO-CLINICAL DIAGNOSTICS GMBH · GM5SLSX6DLH5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- CARLYLE GROUP MANAGEMENT L.L.C. · GLB1EGQHMTM7
- Awarding agency
- Department of War · sub-agency 5700 · office FA5606
- Funding agency
- Department of War · sub-agency 5700
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- FA560618P0001
- Award type code
- B
- Actions
- 12 · Oct 1, 2017 to Dec 13, 2021
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History12
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 13, 2021 | FY2022 | P00011 | M | $0.00 | — |
| Oct 1, 2021 | FY2022 | P00010 | C | $22,923.08 | — |
| Sep 8, 2021 | FY2021 | P00009 | G | $0.00 | — |
| Jun 29, 2021 | FY2021 | P00008 | B | −$880.88 | — |
| Jul 22, 2020 | FY2020 | P00007 | B | $23,101.82 | — |
| Jul 22, 2020 | FY2020 | P00006 | G | $0.00 | — |
| Oct 1, 2019 | FY2020 | P00005 | C | $22,991.74 | — |
| Aug 13, 2019 | FY2019 | P00004 | G | $0.00 | — |
| Oct 1, 2018 | FY2019 | P00003 | C | $23,005.15 | — |
| Aug 15, 2018 | FY2018 | P00002 | G | $0.00 | — |
| Mar 29, 2018 | FY2018 | P00001 | B | −$891.82 | — |
| Oct 1, 2017 | FY2018 | 0 | — | $22,054.88 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.